KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Short-term Investments (2016 - 2025)

Exact Sciences has reported Short-term Investments over the past 16 years, most recently at $8.7 million for Q4 2025.

  • Quarterly Short-term Investments fell 98.01% to $8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.7 million through Dec 2025, down 98.01% year-over-year, with the annual reading at $8.7 million for FY2025, 98.01% down from the prior year.
  • Short-term Investments was $8.7 million for Q4 2025 at Exact Sciences, down from $214.1 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $944.7 million in Q3 2021 and troughed at $8.7 million in Q4 2025.
  • The 5-year median for Short-term Investments is $403.1 million (2022), against an average of $402.9 million.
  • Year-over-year, Short-term Investments soared 209.24% in 2024 and then crashed 98.01% in 2025.
  • A 5-year view of Short-term Investments shows it stood at $715.0 million in 2021, then crashed by 45.52% to $389.6 million in 2022, then crashed by 55.78% to $172.3 million in 2023, then skyrocketed by 153.76% to $437.1 million in 2024, then crashed by 98.01% to $8.7 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Short-term Investments are $8.7 million (Q4 2025), $214.1 million (Q3 2025), and $201.3 million (Q2 2025).